Skip to main content

Find Clinical Trials

Home
Conditions
Relapsed or Refractory Acute Myeloid Leukemia With FLT3 Activating Mutations

Clinical trial condition

Relapsed or Refractory Acute Myeloid Leukemia With FLT3 Activating Mutations

Explore clinical trials studying Relapsed or Refractory Acute Myeloid Leukemia With FLT3 Activating Mutations. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Relapsed or Refractory Acute Myeloid Leukemia With FLT3 Activating Mutations trial results

Completed

Phase II Study of Crenolanib in Subjects With Relapsed/Refractory AML With FLT3 Activating Mutations

NCT01522469

Conditions: Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations: University of Texas Southwestern Medical Center Dallas, Texas, United States

View Trial Details